Trial intelligence / Profile preview

Comparison of 3MIX versus CTZ antibiotic pastes for non-instrumentation root canal treatment in primary molars

RBR-8m8754yNot yet recruiting

Sponsor
Faculdade de Odontologia de Piracicaba
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of metronidazole + ciprofloxacin + minocycline and cetirizine in irreversible pulpitis and pulpal necrosis (2 arms), sponsored by Faculdade de Odontologia de Piracicaba. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

metronidazole + ciprofloxacin + minocyclinecetirizine
03

Conditions

irreversible pulpitispulpal necrosis

Beyond the preview

Go deeper on RBR-8m8754y.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-8m8754y.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call